Mikael Hoffmann

1.4k total citations
49 papers, 973 citations indexed

About

Mikael Hoffmann is a scholar working on Geriatrics and Gerontology, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Mikael Hoffmann has authored 49 papers receiving a total of 973 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Geriatrics and Gerontology, 12 papers in Endocrinology, Diabetes and Metabolism and 12 papers in Genetics. Recurrent topics in Mikael Hoffmann's work include Pharmaceutical Practices and Patient Outcomes (13 papers), Menopause: Health Impacts and Treatments (12 papers) and Estrogen and related hormone effects (11 papers). Mikael Hoffmann is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (13 papers), Menopause: Health Impacts and Treatments (12 papers) and Estrogen and related hormone effects (11 papers). Mikael Hoffmann collaborates with scholars based in Sweden, United States and Denmark. Mikael Hoffmann's co-authors include Björn Wettermark, Susanna M. Wallerstedt, Lotta Lindh‐Åstrand, Mats Hammar, Karin Kjellgren, Karolina Andersson Sundell, Lars L. Gustafsson, Alan Haycox, Brian Godman and Jan Brynhildsen and has published in prestigious journals such as PLoS ONE, Human Reproduction and BJOG An International Journal of Obstetrics & Gynaecology.

In The Last Decade

Mikael Hoffmann

45 papers receiving 943 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mikael Hoffmann Sweden 15 227 189 161 124 121 49 973
Sudeep Karve United States 20 243 1.1× 124 0.7× 83 0.5× 99 0.8× 204 1.7× 63 1.5k
Kavita V. Nair United States 16 201 0.9× 166 0.9× 56 0.3× 41 0.3× 142 1.2× 69 891
John D. Voss United States 14 178 0.8× 250 1.3× 159 1.0× 33 0.3× 119 1.0× 25 970
David Hutchins United States 15 303 1.3× 100 0.5× 61 0.4× 62 0.5× 244 2.0× 23 933
Jonathan H. Watanabe United States 16 230 1.0× 73 0.4× 176 1.1× 31 0.3× 241 2.0× 63 973
Marion Schaefer Germany 16 94 0.4× 121 0.6× 96 0.6× 55 0.4× 407 3.4× 53 1.0k
Kerry McBrien Canada 21 231 1.0× 298 1.6× 211 1.3× 111 0.9× 83 0.7× 109 1.6k
Hassan Fouayzi United States 20 188 0.8× 126 0.7× 93 0.6× 26 0.2× 149 1.2× 44 1.5k
Jay Desai United States 21 151 0.7× 635 3.4× 186 1.2× 90 0.7× 60 0.5× 59 1.5k
Connie Mah Trinacty United States 18 112 0.5× 290 1.5× 266 1.7× 26 0.2× 111 0.9× 36 1.2k

Countries citing papers authored by Mikael Hoffmann

Since Specialization
Citations

This map shows the geographic impact of Mikael Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikael Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikael Hoffmann more than expected).

Fields of papers citing papers by Mikael Hoffmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikael Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikael Hoffmann. The network helps show where Mikael Hoffmann may publish in the future.

Co-authorship network of co-authors of Mikael Hoffmann

This figure shows the co-authorship network connecting the top 25 collaborators of Mikael Hoffmann. A scholar is included among the top collaborators of Mikael Hoffmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikael Hoffmann. Mikael Hoffmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Hammar, Tora, Mikael Hoffmann, & Lina Nilsson. (2023). Challenges with Medication Management and the National Medication List in Sweden: An Interview Study from a Human, Organizational, and Technology Perspective. Studies in health technology and informatics. 302. 287–291. 3 indexed citations
4.
Hoffmann, Mikael. (2023). Timeline of and Expectations for the National Medication List in Sweden. Studies in health technology and informatics. 302. 327–331. 2 indexed citations
5.
Bäckryd, Emmanuel, Markus Heilig, & Mikael Hoffmann. (2021). Opioid availability statistics from the International Narcotics Control Board do not reflect the medical use of opioids: comparison with sales data from Scandinavia. Scandinavian Journal of Pain. 21(4). 696–706. 3 indexed citations
6.
Hoffmann, Mikael, Peter M. Nilsson, Johan Ahlner, et al.. (2020). Do patients or their physicians more accurately assess long-term risk associated with hypertension? A population-based study. Scandinavian Journal of Primary Health Care. 38(2). 166–175. 2 indexed citations
7.
Wallerstedt, Susanna M. & Mikael Hoffmann. (2019). Evidence synthesis based on non-randomised studies—a critical review of studies leading to conclusions on fall risk properties of loop diuretics/beta-blockers. European Journal of Clinical Pharmacology. 75(12). 1731–1738. 4 indexed citations
8.
Bäckryd, Emmanuel, Markus Heilig, & Mikael Hoffmann. (2017). [Opioid prescription changes in Sweden 2000–2015].. PubMed. 114. 13 indexed citations
9.
Bäckryd, Emmanuel, Markus Heilig, & Mikael Hoffmann. (2017). Dynamiken i förskrivningen av opioider i Sverige 2000–2015 - Markanta omfördelningar inom opioidgruppen, men ingen »epidemi«. Läkartidningen. 114. 3 indexed citations
10.
Giske, Christian G., Mats Fredrikson, Åse Östholm Balkhed, et al.. (2016). 14-Year Survey in a Swedish County Reveals a Pronounced Increase in Bloodstream Infections (BSI). Comorbidity - An Independent Risk Factor for Both BSI and Mortality. PLoS ONE. 11(11). e0166527–e0166527. 47 indexed citations
11.
Hoffmann, Mikael, et al.. (2015). [Clinical decision support can provide assistance in complex health care].. PubMed. 111(43). 1906–10. 1 indexed citations
12.
Hoffmann, Mikael. (2013). The right drug, but from whose perspective? A framework for analysing the structure and activities of drug and therapeutics committees. European Journal of Clinical Pharmacology. 69(S1). 79–87. 18 indexed citations
13.
Pettersson, Billie, Mikael Hoffmann, David Andersson, Per Wändell, & Lars‐Åke Levin. (2012). Utilization and costs of glucose lowering therapies following health technology assessment for the new reimbursement scheme in Sweden. Health Policy. 108(2-3). 207–215. 25 indexed citations
14.
Godman, Brian, Björn Wettermark, Mikael Hoffmann, et al.. (2009). Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance. Expert Review of Pharmacoeconomics & Outcomes Research. 9(1). 65–83. 124 indexed citations
15.
Lindh‐Åstrand, Lotta, Jan Brynhildsen, Mikael Hoffmann, Karin Kjellgren, & Mats Hammar. (2007). Knowledge of reproductive physiology and hormone therapy in 53- to 54-year-old Swedish women. Menopause The Journal of The North American Menopause Society. 14(6). 1039–1046. 6 indexed citations
16.
Lindh‐Åstrand, Lotta, Mikael Hoffmann, Mats Hammar, & Karin Kjellgren. (2007). Women's conception of the menopausal transition – a qualitative study. Journal of Clinical Nursing. 16(3). 509–517. 41 indexed citations
17.
Hoffmann, Mikael. (2006). Risk Talk : On Communicating Benefits and Harms in Health Care. European Journal of Radiology. 81(10). 2500–6. 1 indexed citations
18.
Gustafsson, Lars L., et al.. (2003). [Computerized decision support in drug prescribing II: A national database to provide up-to-date and unbiased information].. PubMed. 100(15). 1338–40, 1343. 2 indexed citations
19.
Hanberger, Håkan, et al.. (1997). High Incidence of Antibiotic Resistance Among Bacteria in 4 Intensive Care Units at a University Hospital in Sweden. Scandinavian Journal of Infectious Diseases. 29(6). 607–614. 34 indexed citations
20.
Hoffmann, Mikael & Johan Ahlner. (1995). [Drug utilization should be analyzed on the premises].. PubMed. 92(41). 3808–10. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sudeep Karve Breakdown of academic impact, for papers by Kavita V. Nair Breakdown of academic impact, for papers by John D. Voss Breakdown of academic impact, for papers by David Hutchins Breakdown of academic impact, for papers by Jonathan H. Watanabe Breakdown of academic impact, for papers by Marion Schaefer Breakdown of academic impact, for papers by Kerry McBrien Breakdown of academic impact, for papers by Hassan Fouayzi Breakdown of academic impact, for papers by Jay Desai Breakdown of academic impact, for papers by Connie Mah Trinacty
Rankless by CCL
2026